PHARMA PATENTS CREATE UNFAIR MONOPOLIES

Pharmaceutical patents create monopolies. This article in the Harvard Business Review, titled How Pharma Companies Game the System to Keep Drugs Expensive, by Erin Fox at the University of Utah hospital explains the cunning tactics involved to rip off patients. 

THE IMPACT IS SICKENING

The impact of this is especially damaging to patients in the United States. Who can forget the tragic case of Alec Raeshawn Smith, whose body stopped producing insulin when he was 24 – he had become a Type 1 diabetic. This article How Insulin Became Unaffordable published in the Harvard Politics Review is a heart rending. It's an account of how this young man ceased to be covered by his parent's insurance, and without anyone knowing, began to ration his insulin, with fatal results - impossible not to shed a tear over this sickening tragedy, nor wonder how the executive boards within the pharmaceutical companies sleep at night.

IT'S NOT JUST COSTING TAXPAYERS

SARS-CoV-2 injections, all with patent protection, didn't just earn $100+ billions, we now know the damage they have done. By signing and sharing this update, you could well be contributing to saving millions of lives in the future.